Patents by Inventor Michael Zeligs

Michael Zeligs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240161339
    Abstract: A method and system for correcting alignment of images received from cameras by estimating camera alignment parameters based on perturbative correction such that corrected alignment parameters satisfy pairwise epipolar constraints as well as global loop closure constraints. The corrected alignment parameters are estimated as a Least-Mean-Square solution to a system of linear equations and an estimation algorithm may be implemented as a part of a Random Sample Consensus criterion estimation for improved robustness. The method and system is fast and efficient and may be implemented in a real-time system.
    Type: Application
    Filed: November 3, 2022
    Publication date: May 16, 2024
    Applicant: GM GLOBAL TECHNOLOGY OPERATIONS LLC
    Inventors: Michael Slutsky, Yuval Zelig, Lior Stein, Avi Resler
  • Patent number: 11980604
    Abstract: Provided herein are methods of enhancing mechanical thrombectomy during endovascular therapy for acute thrombosis using 3,3?-diindolylmethane.
    Type: Grant
    Filed: November 9, 2022
    Date of Patent: May 14, 2024
    Assignee: Boulder BioScience LLC
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Publication number: 20240131005
    Abstract: Provided herein are methods of treating non-hemorrhagic closed head injury (NHCHI) with 3,3?-diindolylmethane or an analog thereof. In one embodiment, NHCHI covers Traumatic Brain Injuries (TBIs) including mild to severe concussion, blast injury due to proximity to explosions, cerebral contusion, coup-contrecoup injury, DAI, Second Impact Syndrome, or CHI associated with deceleration injury.
    Type: Application
    Filed: September 27, 2023
    Publication date: April 25, 2024
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Publication number: 20230104863
    Abstract: Provided herein are methods of enhancing mechanical thrombectomy during endovascular therapy for acute thrombosis using 3,3?-diindolylmethane.
    Type: Application
    Filed: November 9, 2022
    Publication date: April 6, 2023
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Patent number: 11529331
    Abstract: Provided herein are methods of enhancing mechanical thrombectomy during endovascular therapy for acute thrombosis using 3,3?-diindolylmethane.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: December 20, 2022
    Assignee: Boulder BioScience LLC
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Publication number: 20220280479
    Abstract: Disclosed herein are self-emulsifying compositions and formulations of Diindolylmethane (“DIM”) and certain derivatives of DIM, their uses and methods of making. In particular, the disclosed compositions comprise a DIM-related indole as an active agent and a carrier, wherein the carrier comprises a solvent, one or more surfactants with an HLB of greater than 7, and one or more co-surfactants with an HLB equal to or less than 7. In certain aspects of the invention, the compositions disclosed herein show improved bioavailability.
    Type: Application
    Filed: May 19, 2022
    Publication date: September 8, 2022
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Patent number: 11337961
    Abstract: Disclosed herein are self-emulsifying compositions and formulations of Dimdolylmethane (“DIM”) and certain derivatives of DIM, their uses and methods of making. In particular, the disclosed compositions comprise a DIM-related indole as an active agent and a carrier, wherein the carrier comprises a solvent, one or more surfactants with an HLB of greater than 7, and one or more co-surfactants with an HLB equal to or less than 7. In certain aspects of the invention, the compositions disclosed herein show improved bioavailability.
    Type: Grant
    Filed: September 1, 2020
    Date of Patent: May 24, 2022
    Assignee: Bioresponse, L.L.C.
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Publication number: 20220008387
    Abstract: Provided herein are methods of enhancing mechanical thrombectomy during endovascular therapy for acute thrombosis using 3,3?-diindolylmethane.
    Type: Application
    Filed: May 27, 2021
    Publication date: January 13, 2022
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Publication number: 20210046046
    Abstract: Disclosed herein are self-emulsifying compositions and formulations of Dimdolylmethane (“DIM”) and certain derivatives of DIM, their uses and methods of making. In particular, the disclosed compositions comprise a DIM-related indole as an active agent and a carrier, wherein the carrier comprises a solvent, one or more surfactants with an HLB of greater than 7, and one or more co-surfactants with an HLB equal to or less than 7. In certain aspects of the invention, the compositions disclosed herein show improved bioavailability.
    Type: Application
    Filed: September 1, 2020
    Publication date: February 18, 2021
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Patent number: 10799479
    Abstract: Disclosed herein are self-emulsifying compositions and formulations of Dimdolylmethane (“DIM”) and certain derivatives of DIM, their uses and methods of making. In particular, the disclosed compositions comprise a DIM-related indole as an active agent and a carrier, wherein the carrier comprises a solvent, one or more surfactants with an HLB of greater than 7, and one or more co-surfactants with an HLB equal to or less than 7. In certain aspects of the invention, the compositions disclosed herein show improved bioavailability.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: October 13, 2020
    Assignee: BioResponse, L.L.C.
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Patent number: 10441569
    Abstract: Disclosed herein are self-emulsifying compositions and formulations of Diindolylmethane (“DIM”) and certain derivatives of DIM, their uses and methods of making. In particular, the disclosed compositions comprise a DIM-related indole as an active agent and a carrier, wherein the carrier comprises a solvent, one or more surfactants with an HLB of greater than 7, and one or more co-surfactants with an HLB equal to or less than 7. In certain aspects of the invention, the compositions disclosed herein show improved bioavailability.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: October 15, 2019
    Assignee: BioResponse, L.L.C.
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Publication number: 20180280347
    Abstract: Disclosed herein are self-emulsifying compositions and formulations of Dimdolylmethane (“DIM”) and certain derivatives of DIM, their uses and methods of making. In particular, the disclosed compositions comprise a DIM-related indole as an active agent and a carrier, wherein the carrier comprises a solvent, one or more surfactants with an HLB of greater than 7, and one or more co-surfactants with an HLB equal to or less than 7. In certain aspects of the invention, the compositions disclosed herein show improved bioavailability.
    Type: Application
    Filed: April 8, 2016
    Publication date: October 4, 2018
    Applicant: BioResponse, L.L.C.
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Publication number: 20180161308
    Abstract: Disclosed herein are self-emulsifying compositions and formulations of Diindolylmethane (“DIM”) and certain derivatives of DIM, their uses and methods of making. In particular, the disclosed compositions comprise a DIM-related indole as an active agent and a carrier, wherein the carrier comprises a solvent, one or more surfactants with an HLB of greater than 7, and one or more co-surfactants with an HLB equal to or less than 7. In certain aspects of the invention, the compositions disclosed herein show improved bioavailability.
    Type: Application
    Filed: December 15, 2017
    Publication date: June 14, 2018
    Applicant: BioResponse, L.L.C.
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Patent number: 9918965
    Abstract: Disclosed herein are self-emulsifying compositions and formulations of Diindolylmethane (“DIM”) and certain derivatives of DIM, their uses and methods of making. In particular, the disclosed compositions comprise a DIM-related indole as an active agent and a carrier, wherein the carrier comprises a solvent, one or more surfactants with an HLB of greater than 7, and one or more co-surfactants with an HLB equal to or less than 7. In certain aspects of the invention, the compositions disclosed herein show improved bioavailability.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: March 20, 2018
    Assignee: BIORESPONSE, L.L.C.
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Patent number: 9663462
    Abstract: The present invention includes methods and compositions for the treatment and prevention of protozoal parasitic infections utilizing Diindolylmethane-related indoles. Additive and synergistic interaction of Diindolylmethane-related indoles with other known anti-parasitic and pro-apoptotic agents is believed to permit more effective therapy and prevention of protozoal parasitic infections. The methods and compositions described provide new treatment of protozoal parasitic diseases of mammals and birds including malaria, leishmaniasis, trypanosomiasis, trichomoniasis, neosporosis and coccidiosis.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: May 30, 2017
    Assignee: BioResponse, L.L.C.
    Inventor: Michael A. Zeligs
  • Publication number: 20170014382
    Abstract: Disclosed herein are self-emulsifying compositions and formulations of Diindolylmethane (“DIM”) and certain derivatives of DIM, their uses and methods of making. In particular, the disclosed compositions comprise a DIM-related indole as an active agent and a carrier, wherein the carrier comprises a solvent, one or more surfactants with an HLB of greater than 7, and one or more co-surfactants with an HLB equal to or less than 7. In certain aspects of the invention, the compositions disclosed herein show improved bioavailability.
    Type: Application
    Filed: April 8, 2016
    Publication date: January 19, 2017
    Applicant: BioResponse, L.L.C.
    Inventors: Michael A. Zeligs, Irwin C. Jacobs
  • Patent number: 9353058
    Abstract: The present invention includes methods and compositions for the treatment and prevention of protozoal parasitic infections utilizing Diindolylmethane-related indoles. Additive and synergistic interaction of Diindolylmethane-related indoles with other known anti-parasitic and pro-apoptotic agents is believed to permit more effective therapy and prevention of protozoal parasitic infections. The methods and compositions described provide new treatment of protozoal parasitic diseases of mammals and birds including malaria, leishmaniasis, trypanosomiasis, trichomoniasis, neosporosis and coccidiosis.
    Type: Grant
    Filed: October 10, 2013
    Date of Patent: May 31, 2016
    Assignee: BioResponse, L.L.C.
    Inventor: Michael A. Zeligs
  • Publication number: 20160101083
    Abstract: The present invention includes methods and compositions for the treatment and prevention of protozoal parasitic infections utilizing Diindolylmethane-related indoles. Additive and synergistic interaction of Diindolylmethane-related indoles with other known anti-parasitic and pro-apoptotic agents is believed to permit more effective therapy and prevention of protozoal parasitic infections. The methods and compositions described provide new treatment of protozoal parasitic diseases of mammals and birds including malaria, leishmaniasis, trypanosomiasis, trichomoniasis, neosporosis and coccidiosis.
    Type: Application
    Filed: December 18, 2015
    Publication date: April 14, 2016
    Applicant: BioResponse, L.L.C.
    Inventor: Michael A. Zeligs
  • Publication number: 20140037577
    Abstract: The present invention includes methods and compositions for the treatment and prevention of protozoal parasitic infections utilizing Diindolylmethane-related indoles. Additive and synergistic interaction of Diindolylmethane-related indoles with other known anti-parasitic and pro-apoptotic agents is believed to permit more effective therapy and prevention of protozoal parasitic infections. The methods and compositions described provide new treatment of protozoal parasitic diseases of mammals and birds including malaria, leishmaniasis, trypanosomiasis, trichomoniasis, neosporosis and coccidiosis.
    Type: Application
    Filed: October 10, 2013
    Publication date: February 6, 2014
    Inventor: Michael A. Zeligs
  • Patent number: 8586621
    Abstract: The present invention includes methods and compositions for the treatment and prevention of protozoal parasitic infections utilizing Diindolylmethane-related indoles. Additive and synergistic interaction of Diindolylmethane-related indoles with other known anti-parasitic and pro-apoptotic agents is believed to permit more effective therapy and prevention of protozoal parasitic infections. The methods and compositions described provide new treatment of protozoal parasitic diseases of mammals and birds including malaria, leishmaniasis, trypanosomiasis, trichomoniasis, neosporosis and coccidiosis.
    Type: Grant
    Filed: October 26, 2007
    Date of Patent: November 19, 2013
    Inventor: Michael A. Zeligs